Huakang Zhongtai Completes RMB 30 Million Pre-A Financing to Advance AI-Powered Disease Prevention and Health Management Solutions for Hospital体检 Centers

Huakang Zhongtai CEO Tan Peiyu (left) and Furui Zhi Holdings Chairman Tang Wen (right) at the investment signing ceremony

VCBeat recently learned that Huakang Zhongtai, a startup dedicated to providing hospitals’ health examination centers with an integrated intelligent IT solution for health management based on disease prevention and related big data analytics through AI algorithms, has announced the completion of its RMB 30 million Pre-A financing round. This round was led by Furui Zhi Holdings, a leading domestic investment group focused on low-carbon environmental protection and the broader health industry. The investment in Huakang Zhongtai will further enrich and enhance Furui Zhi Holdings’ strategic layout within the health sector.

Huakang Zhongtai has established a dynamic health risk assessment model tailored to common chronic non-communicable diseases by integrating big data and artificial intelligence with traditional statistical methods for modeling the relationship between disease risk and risk factors, building on years of practical experience and accumulated expertise in the health industry.

Building on its health risk assessment engine, Huakang Zhongtai has developed a “Health Management Business Support Platform” tailored to the specific needs of hospitals and aligned with post-examination workflows. The platform also enables real-time interaction between health managers and their clients, assisting medical institutions in carrying out health management services through multiple channels, including PC, smartphones, and instant messaging (IM) platforms.

According to the Report on the Nutritional and Chronic Disease Status of Chinese Residents, nearly 40% of the Chinese population suffers from more than one chronic disease, making chronic diseases a major public health issue affecting the nation’s economic and social development. Huakang Zhongtai has established in-depth collaborations with dozens of public hospitals, including the Health Management Center of Sichuan Provincial People’s Hospital, through its personalized health risk assessment model, health management business support platform, and chronic disease intervention solutions. These partnerships have significantly improved the efficiency of chronic disease management for cooperating medical institutions and achieved revenue growth exceeding 15%.

The Huakang team comprises professionals from diverse fields, including clinical medicine, preventive medicine, computer science, and finance. With years of hands-on experience in artificial intelligence and big data, the team has established deep expertise in vertical domains and cross-industry resource integration.

The report of the 19th National Congress of the Communist Party of China explicitly proposed the “Healthy China Strategy.” Providing comprehensive, full-cycle health services to the public represents a new challenge in addressing the complex situation characterized by the interplay and superposition of multiple health factors against the backdrop of China’s industrialization, urbanization, population aging, and changes in the ecological environment and lifestyle. Society as a whole will shift its focus from disease treatment to prevention and an integrated approach combining prevention and control. Consequently, preventive medicine, particularly health management for chronic diseases, will gradually become a key priority for the state, hospitals, and individuals alike. Following the completion of this round of financing, Huakang Zhongtai is planning to establish joint laboratories with relevant domestic partners to deepen collaboration. By leveraging Huakang’s technology to build a scientific research data platform, the company aims to expand the depth and breadth of its digital prevention and control solutions for chronic disease management, thereby better serving its partner medical institutions.